QUALITY OF LIFE AFTER SURGICAL TREATMENT OF INSULIN-PRODUCTION TUMORS OF THE PANCREAS


Cite item

Full Text

Abstract

Background: insulinoma is a neuroendocrine tumor characterized by hyperproduction of insulin and hypoglycemia that decrease patient's quality of life. The only curative method of treatment is surgery. Aim: studying the quality of life of patients after various options for surgical treatment of insulin-producing pancreatic tumors. Materials and methods: 48 patients operated in the First Moscow State Medical University were included in the quality of life study. Patients were divided into two groups: those who underwent tumor enucleation (n 28), and patients who underwent resection of the pancreas (n 20). The study was performed using the questionnaire SF-36, not earlier than 3 months after surgery. Results: in the study of quality of life, a significant difference was only in a scale of role-physical functioning, which was higher in patients that underwent tumor enucleation, as opposed to patients after resection procedures. Conclusion: the quality of life in both groups remained at a high level; the differences were noted only in the scale of role-physical functioning, which was higher in patients after tumor enucleation.

About the authors

D V Lejinskiy

I.M. Sechenov First Moscow State Medical University (Sechenov University)

119991 Trubetskaya str., 8, p. 2, Moscow, Russia

A V Egorov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

119991 Trubetskaya str., 8, p. 2, Moscow, Russia

I A Vasilyev

I.M. Sechenov First Moscow State Medical University (Sechenov University)

119991 Trubetskaya str., 8, p. 2, Moscow, Russia

I V Ivashov

I.M. Sechenov First Moscow State Medical University (Sechenov University)

119991 Trubetskaya str., 8, p. 2, Moscow, Russia

A V Mironova

I.M. Sechenov First Moscow State Medical University (Sechenov University)

119991 Trubetskaya str., 8, p. 2, Moscow, Russia

References

  1. Kulke M.H., Anthony L.B., Bushnell D.L. NANETS Treatment Guidelines: welldiffer- entiated neuroendocrine tumors of the stomach and pancreas // Pancreas.- 2010.-39.-P.735-752.
  2. Jensen R.T., Berna M.J., Bingham M.D. Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management and controversies // Cancer.-2008.-113(suppl).-P.1807-1843.
  3. Oberg K. Pancreatic endocrine tumors // Semin Oncol.-2010.-37.-P.594-618
  4. Guettier J.M., Gorden P. Insulin secretion and insulin-producing tumors. Expert Rev Endocrinol. Metab. 2010; 5: 217-227
  5. PadbergВ., Schroder S., Capella C. Multiple endocrine neoplasia type-1 (MEN1) revisited // Virch. Arch. - 1995.- 426. -P. 541-548.
  6. Трофимов В.М., Калинин А.П. Некоторые аспекты диагностики и лечения органического гиперинсулинизма // Клин. мед. - 1991. -№ 3. - С. 102-106
  7. Амирджанова В.Н., Горячев Д.В., Коршунов Н.И., Ребров А.П., Сороцкая В.Н. Популяционные показатели качества жизни по опроснику SF-36 (результаты многоцентрового исследования качества жизни «МИРАЖ») // Научно-практическая ревматология.-2008.-№1.-Стр.36-48.

Copyright (c) 2019 Lejinskiy D.V., Egorov A.V., Vasilyev I.A., Ivashov I.V., Mironova A.V.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies